Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs

Chronic autoimmune inflammation is one of the leading risk factors for the development of chronic heart failure (CHF) in rheumatoid arthritis (RA). The purpose of the review is to analyze the results of investigations on the effects of conventional synthetic disease-modifying anti-rheumatic drugs (c...

Full description

Bibliographic Details
Main Authors: D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova
Format: Article
Language:English
Published: Столичная издательская компания 2020-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
rheumatoid arthritis
chronic heart failure
conventional synthetic disease-modifying anti-rheumatic drugs
targeted conventional synthetic disease-modifying anti-rheumatic drugs
biological disease-modifying anti-rheumatic drugs
cardiac function
n-terminal prohormone of brain natriuretic peptide.
Online Access:https://www.rpcardio.online/jour/article/view/2074

Similar Items

Similar Items